Showing results (1-10 of 131) with videos related to

Sort By:
Pageof 14
British Journal of Pharmacology|October 17, 2022
Cannabinoid 1 (CB1 ) receptor arrestin subtype-selectivity and phosphorylation dependenceJamie J Manning, Gabriel Rawcliffe, David B Finlay, et al.
Neuropharmacology|May 17, 2021
Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and biasJamie J Manning, Hayley M Green, Michelle Glass, et al.
Biochemical Pharmacology|February 24, 2020
Signalling profiles of a structurally diverse panel of synthetic cannabinoid receptor agonistsMonica Patel, Jamie J Manning, David B Finlay, et al.
Cellular Signalling|December 1, 2020
Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonistsMonica Patel, David B Finlay, Michelle Glass
ACS Chemical Neuroscience|September 13, 2019
Do Toxic Synthetic Cannabinoid Receptor Agonists Have Signature in Vitro Activity Profiles? A Case Study of AMB-FUBINACADavid B Finlay, Jamie J Manning, Mikkel Søes Ibsen, et al.
British Journal of Pharmacology|January 25, 2020
100 years of modelling ligand-receptor binding and response: A focus on GPCRsDavid B Finlay, Stephen B Duffull, Michelle Glass
British Journal of Pharmacology|February 20, 2018
An evaluation of the operational model when applied to quantify functional selectivityXiao Zhu, David B Finlay, Michelle Glass, et al.
British Journal of Pharmacology|April 16, 2020
Evaluation of the profiles of CB1 cannabinoid receptor signalling bias using joint kinetic modellingXiao Zhu, David B Finlay, Michelle Glass, et al.
Pageof 14